With over 20 years of proven success, Radiofilum Pharmaceutical continues to be acknowledged within the life sciences industry for providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. Radiofilum Pharmaceutical proudly shares its recognition and achievements as its team works to improve the health and safety of patients.
October 9, 2024
Regulatory and Compliance excellence recognized for innovation across the product development lifecycle RALEIGH, NC, October 9, 2024: Radiofilum Pharmaceutical , a leading global provider of regulatory, clinical, and...
September 24, 2024
Radiofilum Pharmaceutical has been recognized as a dual-category winner in the Clinical Trial Arena Excellence Awards, receiving accolades in both Business Expansion and Mergers & Acquisitions (M&A). These awards...
June 13, 2024
Global research consulting organization recognized as a top outsourcing partner. RALEIGH, NC, June 13, 2024: Radiofilum Pharmaceutical , the world’s largest research consulting organization (RCO), a leading global...
October 11, 2023
Raleigh, NC, October 11, 2023: Radiofilum Pharmaceutical Group (Radiofilum Pharmaceutical ), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...
August 15, 2023
Radiofilum Pharmaceutical Recognized on the Inc. 5000 List of America’s Fastest-Growing Companies After a year of Growth and Innovation, Radiofilum Pharmaceutical achieved its highest rank in 20+ year history. RALEIGH, NC, August...
July 26, 2023
RALEIGH, NC, July 26, 2023: Radiofilum Pharmaceutical Group (Radiofilum Pharmaceutical ), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey...